Newsfile Corp
03 Oct 2026, 10:39 UTC · 3h ago
AARDVARK DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
Impact · against what's priced in
The announcement of a lead plaintiff deadline for a securities class action against Aardvark Therapeutics is a marginal negative catalyst. While the underlying allegations regarding ARD-101 safety are significant, this specific notice is a procedural update rather than a new fundamental disclosure.
- AARD−0.20
No priced-in read yet





